Bottom line
How much do AHSZX and RYHIX overlap?
37% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 29.8% of AHSZX's assets and 17.3% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
RYHIX holds far more positions (135 vs 55), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings AHSZX and RYHIX have in common
| Holding | % of AHSZX | % of RYHIX | Overlap |
|---|---|---|---|
| Merck & Company Inc MRK | 4.18% | 2.04% | 2.04% |
| Johnson & Johnson JNJ | 4.06% | 2.88% | 2.88% |
| Thermo Fisher Scientific Inc TMO | 4.00% | 1.61% | 1.61% |
| Cvs Health Corp CVS | 3.67% | 1.31% | 1.31% |
| Unitedhealth Group Inc UNH | 3.61% | 2.22% | 2.22% |
| Eli Lilly & Company LLY | 3.29% | 3.63% | 3.29% |
| Abbott Laboratories ABT | 2.93% | 1.42% | 1.42% |
| Novo Nordisk A/s NVO | 2.24% | 0.83% | 0.83% |
| Vertex Pharmaceuticals Inc VRTX | 1.80% | 1.34% | 1.34% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in AHSZX
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Welltower Inc — 4.12%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Teva Pharmaceutical Industries Ltd — 3.53%
- 10x Genomics Inc — 2.26%
- Repligen Corp — 2.21%
- Royalty Pharma Plc — 1.94%
- Centene Corp — 1.91%
- Incyte Corp — 1.86%
- Pennant Group Inc (the) — 1.83%
- Arrowhead Pharmaceuticals Inc — 1.81%
- Guardant Health Inc — 1.81%
- Corteva Inc — 1.65%
Only in RYHIX
- Abbvie Inc — 2.52%
- Amgen Inc — 1.56%
- Gilead Sciences Inc — 1.39%
- Intuitive Surgical Inc — 1.31%
- Danaher Corp — 1.30%
- Pfizer Inc — 1.25%
- Bristol-myers Squibb Company — 1.22%
- Stryker Corp — 1.21%
- Mckesson Corp — 1.05%
- Elevance Health Inc — 1.02%
- Cigna Group (the) — 0.94%
- Regeneron Pharmaceuticals Inc — 0.90%
- Hca Healthcare Inc — 0.87%
- Cardinal Health Inc — 0.86%
- Boston Scientific Corp — 0.86%
Asset mix
| Asset type | AHSZX | RYHIX |
|---|---|---|
| Stocks | 91.9% | 83.2% |
| Cash & short-term funds | 6.5% | — |
| Repurchase agreements | — | 0.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | AHSZX | RYHIX |
|---|---|---|
| US | 87.0% | 73.0% |
| IL | 3.5% | 0.6% |
| IE | — | 3.3% |
| CH | 1.3% | 2.3% |
| DK | 2.2% | 1.4% |
| GB | 1.9% | 1.8% |
| FR | 1.6% | — |
| BM | 0.9% | 0.5% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do AHSZX and RYHIX overlap?
What stocks do AHSZX and RYHIX have in common?
Should I own both AHSZX and RYHIX?
Which holds more stocks, AHSZX or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.